Search Results - "Lissoni, A"

Endometriomas: their ultrasound characteristics by Van Holsbeke, C., Van Calster, B., Guerriero, S., Savelli, L., Paladini, D., Lissoni, A. A., Czekierdowski, A., Fischerova, D., Zhang, J., Mestdagh, G., Testa, A. C., Bourne, T., Valentin, L., Timmerman, D.

“…Objectives To describe the ultrasound characteristics of endometriomas in pre‐ and postmenopausal patients and to develop rules that characterize…”
Get full text

Ovarian cancer prediction in adnexal masses using ultrasound‐based logistic regression models: a temporal and external validation study by the IOTA group by Timmerman, D., Van Calster, B., Testa, A. C., Guerriero, S., Fischerova, D., Lissoni, A. A., Van Holsbeke, C., Fruscio, R., Czekierdowski, A., Jurkovic, D., Savelli, L., Vergote, I., Bourne, T., Van Huffel, S., Valentin, L.

“…Objectives The aims of the study were to temporally and externally validate the diagnostic performance of two logistic regression models containing clinical…”
Get full text

Oral microbiome and mucosal trauma as risk factors for oral cancer: beyond alcohol and tobacco. A literature review by Lissoni, A, Agliardi, E, Peri, A, Marchioni, R, Abati, S

“…Oral and oropharyngeal cancer represents the sixth more common type of cancer affecting the worldwide population. It has been estimated the number of 650,000…”
Get more information

Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses by Sokalska, A., Timmerman, D., Testa, A. C., Van Holsbeke, C., Lissoni, A. A, Leone, F. P. G., Jurkovic, D., Valentin, L.

“…Objectives To determine the sensitivity and specificity of subjective evaluation of gray‐scale and Doppler ultrasound findings (here called pattern…”
Get full text

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma : results of a randomised trial by MAGGI, R, LISSONI, A, SPINA, F, MELPIGNANO, M, ZOLA, P, FAVALLI, G, COLOMBO, A, FOSSATI, R

“…Patients with high-risk endometrial carcinoma (stage IcG3, IIG3 with myometrial invasion >50%, and III) receive adjuvant therapy after surgery but it is not…”
Get full text

Optimal treatment of early-stage ovarian cancer by Collinson, F., Qian, W., Fossati, R., Lissoni, A., Williams, C., Parmar, M., Ledermann, J., Colombo, N., Swart, A.

“…There is no clear consensus regarding systemic treatment of early-stage ovarian cancer (OC). Clinical trials are challenging because of the relatively low…”
Get full text

A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study by Lissoni, A. A., Colombo, N., Pellegrino, A., Parma, G., Zola, P., Katsaros, D., Chiari, S., Buda, A., Landoni, F., Peiretti, M., Dell'Anna, T., Fruscio, R., Signorelli, M., Grassi, R., Floriani, I., Fossati, R., Torri, V., Rulli, E.

“…Background: The efficacy and tolerability of the regimen containing paclitaxel and cisplatin (TP) in the neo-adjuvant treatment of locally advanced squamous…”
Get full text

Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray‐scale and Doppler ultrasound findings: logistic regression models do not help by Valentin, L., Ameye, L., Savelli, L., Fruscio, R., Leone, F. P. G., Czekierdowski, A., Lissoni, A. A., Fischerova, D., Guerriero, S., Van Holsbeke, C., Van Huffel, S., Timmerman, D.

“…Objective To develop a logistic regression model that can discriminate between benign and malignant adnexal masses perceived to be difficult to classify by…”
Get full text

Clinically oriented three‐step strategy for assessment of adnexal pathology by Ameye, L., Timmerman, D., Valentin, L., Paladini, D., Zhang, J., Van Holsbeke, C., Lissoni, A. A., Savelli, L., Veldman, J., Testa, A. C., Amant, F., Van Huffel, S., Bourne, T.

“…Objective To determine the diagnostic performance of ultrasound‐based simple rules, risk of malignancy index (RMI), two logistic regression models (LR1 and…”
Get full text

Artificial lung as an alternative to mechanical ventilation in COPD exacerbation by Crotti, S, Lissoni, A, Tubiolo, D, Azzari, S, Tarsia, P, Caspani, L, Gattinoni, L

Get full text

Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale by CAVALETTI, G, BOGLIUN, G, ZANNA, C, MARZORATI, L, ZINCONE, A, PIATTI, M, COLOMBO, N, PARMA, G, LISSONI, A, FEI, F, CUNDARI, S

“…The authors compared clinically based neurotoxicity scales with the Total Neuropathy Scale, with the aim of improving the grading of the severity of…”
Get full text

Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary by Dierickx, I., Valentin, L., Van Holsbeke, C., Jacomen, G., Lissoni, A. A., Licameli, A., Testa, A., Bourne, T., Timmerman, D.

“…ABSTRACT Objectives To describe clinical and ultrasound features of Brenner tumors of the ovary. Methods In this retrospective study, the databases of the…”
Get full text

Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis by MAGGIONI, A, BENEDETTI PANICI, P, ANGIOLI, R, MANCI, N, CALCAGNO, M, SCAMBIA, G, FOSSATI, R, FLORIANI, I, TORRI, V, GRASSI, R, MANGIONI, C, DELL'ANNA, T, LANDONI, F, LISSONI, A, PELLEGRINO, A, ROSSI, R. S, CHIARI, S, CAMPAGNUTTA, E, GREGGI, S

“…No randomised trials have addressed the value of systematic aortic and pelvic lymphadenectomy (SL) in ovarian cancer macroscopically confined to the pelvis…”
Get full text

Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer by LHOMME, Catherine, JOLY, Florence, JONES, Gary J, DUGAN, Margaret H, WALKER, Joan L, LISSONI, Andrea A, NICOLETTO, Maria O, MANIKHAS, Gregory M, BAEKELANDT, Mark M. O, GORDON, Alan N, FRACASSO, Paula M, MIETLOWSKI, William L

“…To compare the safety and efficacy of carboplatin and paclitaxel administered with or without the multidrug resistance modulator valspodar (PSC 833) in…”
Get full text

Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature by Valentin, L., Ameye, L., Franchi, D., Guerriero, S., Jurkovic, D., Savelli, L., Fischerova, D., Lissoni, A., Van Holsbeke, C., Fruscio, R., Van Huffel, S., Testa, A., Timmerman, D.

“…ABSTRACT Objectives The aim of this study was to estimate the rate of malignancy in adnexal lesions described as unilocular cysts at transvaginal ultrasound…”
Get full text

BAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib with continuous schedule vs cediranib-olaparib with intermittent schedule in advanced platinum resistant ovarian cancer by Colombo, N., Nicoletto, O., Benedetti Panici, P., Tognon, G., Lissoni, A.A., Bologna, A., Tomao, F., Fossati, R., Tettamanzi, F., Rulli, E., Galli, F., Alvisi, M.F., Torri, V., Biagioli, E.

Get full text

Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can classify them reliably as benign or malignant before surgery? by Valentin, L., Ameye, L., Savelli, L., Fruscio, R., Leone, F. P. G., Czekierdowski, A., Lissoni, A. A., Fischerova, D., Guerriero, S., Van Holsbeke, C., Van Huffel, S., Timmerman, D.

“…ABSTRACT Objectives To develop a logistic regression model for discrimination between benign and malignant unilocular solid cysts with papillary projections…”
Get full text

Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses by Di Legge, A., Testa, A. C., Ameye, L., Van Calster, B., Lissoni, A. A., Leone, F. P. G., Savelli, L., Franchi, D., Czekierdowski, A., Trio, D., Van Holsbeke, C., Ferrazzi, E., Scambia, G., Timmerman, D., Valentin, L.

“…Objectives To estimate the ability to discriminate between benign and malignant adnexal masses of different size using: subjective assessment, two…”
Get full text

Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease: Different syndromes? by GATTINONI, L, PELOSI, P, SUTER, P. M, PEDOTO, A, VERCESI, P, LISSONI, A

“…To assess the possible differences in respiratory mechanics between the acute respiratory distress syndrome (ARDS) originating from pulmonary disease (ARDSp)…”
Get full text

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy by Cavaletti, G., Bogliun, G., Marzorati, L., Zincone, A., Piatti, M., Colombo, N., Franchi, D., La Presa, M. T., Lissoni, A., Buda, A., Fei, F., Cundari, S., Zanna, C.

“…Background: We investigated the possible use of clinical signs of chemotherapy-induced peripheral neurotoxicity (CIPN) or of nerve growth factor (NGF)…”
Get full text